Fresenius SE & Co. KGaA FRE.DE
DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website
Fresenius SE & Co. KGaA statistics & valuation
Market cap€26.8B
P / E21.2×
P / S1.2×
P / B1.4×
P / FCF24.9×
Dividend yield2.55%
Net margin5.5%
Return on equity6.6%
FCF margin4.7%
Net debt€10.6B
Enterprise value USD$43.3B
Earnings yield EBIT/EV5.8%
Return on capital6.6%
Graham number -13.2%€41.35
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (€41.35); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 24.9% | 25.7% | 23.6% | 25.1% |
| Operating margin | 9.5% | 9.4% | 5.6% | 8.4% |
| Net margin | 5.5% | 2.1% | -2.8% | 6.4% |
| FCF margin | 4.7% | 6.3% | 15.0% | 14.0% |
| Return on assets | 3.1% | 1.1% | -1.3% | 1.8% |
| Return on equity | 6.6% | 2.4% | -3.1% | 6.7% |
| Debt / equity | 0.48× | 0.48× | 0.60× | 0.93× |
| Current ratio | 1.32 | 1.27 | 1.34 | 1.34 |
Computed from company filings · DE · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.